Balance Sheet

  • Company Name :
Parmax Pharma Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 540359
  • NSE Symbol:
  • -
  • P/E(TTM):
  • 0.00
  • ISIN Demat:
  • INE240T01014
  • Div & Yield%:
  • 0.00
  • EPS(TTM):
  • 0.00
  • Book Value(₹):
  • -14.81
  • Market Cap(₹Cr.):
  • 13.28
  • Face Value(₹):
  • 10.00
  Mar'2025 Mar'2024 Mar'2023 Mar'2022 Mar'2021
SOURCES OF FUNDS :          
Equity Share Capital 4.45 4.45 4.45 4.45 4.45
Reserves -6.44 -4.35 1.40 1.51 1.37
Equity Share Warrants 0.00 0.00 0.00 0.00 0.00
Equity Application Money 0.00 0.00 0.00 0.00 0.00
Total Shareholders Funds -1.99 0.10 5.85 5.96 5.82
Secured Loans 5.10 4.33 4.00 3.81 4.27
Unsecured Loans 2.61 1.58 1.37 1.37 1.62
Total Debt 7.71 5.91 5.37 5.18 5.89
Other Liabilities 0.00 0.00 0.00 0.00 0.00
Total Liabilities 5.72 6.01 11.22 11.14 11.71
APPLICATION OF FUNDS :          
Gross Block 17.69 19.87 18.38 17.45 15.92
Less: Accumulated Depreciation 9.72 10.60 8.88 7.00 5.07
Less:Impairment of Assets 0.00 0.00 0.00 0.00 0.00
Net Block 7.97 9.27 9.50 10.45 10.85
Lease Adjustments 0.00 0.00 0.00 0.00 0.00
Capital Work in Progress 0.00 0.10 0.00 0.00 0.00
Investments 0.40 0.00 0.00 0.00 0.20
Current Assets, Loans & Advances          
Inventories 3.31 2.39 4.31 2.85 3.95
Sundry Debtors 1.28 1.82 0.62 0.68 1.65
Cash and Bank Balance 0.09 0.05 0.41 1.05 2.55
Loans and Advances 5.33 1.51 2.19 1.98 2.19
Total Current Assets 10.01 5.77 7.53 6.56 10.34
Less : Current Liabilities and Provisions          
Current Liabilities 12.45 8.98 5.28 5.72 9.96
Provisions 0.59 0.23 0.97 0.93 0.84
Total CL & Provisions 13.04 9.21 6.24 6.65 10.79
Net Current Assets -3.03 -3.44 1.28 -0.09 -0.45
Miscellaneous Expenses not written off 0.00 0.00 0.00 0.00 0.00
Deferred Tax Assets 0.19 0.00 0.00 0.00 0.00
Deferred Tax Liability 0.00 0.11 0.14 0.18 0.23
Net Deferred Tax 0.19 -0.11 -0.14 -0.18 -0.23
Other Assets 0.18 0.18 0.58 0.97 1.35
Total Assets 5.71 6.01 11.22 11.14 11.71
Contingent Liabilities 0.00 1.00 1.00 1.00 1.00